# EDGAR Filing Document

**Accession Number:** 0001320350
**File Stem:** 0001193125-26-253635
**Filing Date:** 2026-6
**Character Count:** 19538
**Document Hash:** 745fd9be4bfee3b8b9c722edaada0ab2
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-26-253635.hdr.sgml**: 20260622

**ACCESSION NUMBER**: 0001193125-26-253635

**CONFORMED SUBMISSION TYPE**: S-8

**PUBLIC DOCUMENT COUNT**: 14

**FILED AS OF DATE**: 20260602

**DATE AS OF CHANGE**: 20260602

**EFFECTIVENESS DATE**: 20260602

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** LENSAR, Inc.
- **CENTRAL INDEX KEY:** 0001320350
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 320125724
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** S-8
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-296424
- **FILM NUMBER:** 261056643

**BUSINESS ADDRESS:**
- **STREET 1:** 2800 DISCOVERY DRIVE
- **STREET 2:** SUITE 100
- **CITY:** ORLANDO
- **STATE:** FL
- **ZIP:** 32826
- **BUSINESS PHONE:** 888-536-7271

**MAIL ADDRESS:**
- **STREET 1:** 2800 DISCOVERY DRIVE
- **STREET 2:** SUITE 100
- **CITY:** ORLANDO
- **STATE:** FL
- **ZIP:** 32826

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** LensAR Inc
- **DATE OF NAME CHANGE:** 20070703

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** LaserSoft Vision Inc
- **DATE OF NAME CHANGE:** 20050310

**As filed with the Securities and Exchange Commission on June 2, 2026** 

**Registration No. 333-** 

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION** 

**Washington, D.C. 20549** 

**FORM S-8** 

**REGISTRATION STATEMENT** 

***Under*** 

***The Securities Act of 1933*** 

**LENSAR, Inc.** 

**(Exact name of registrant as specified in its charter)** 

---

| | |
|:---|:---|
| **Delaware** | **32-0125724** |
| **(State or other jurisdiction of**<br>**incorporation or organization)** | **(I.R.S. Employer**<br>**Identification No.)** |

---

---

| | |
|:---|:---|
| **2800 Discovery Drive,**<br>**Orlando, Florida** | **32826** |
| **(Address of Principal Executive Offices)** | **(Zip Code)** |

---

**2020 Incentive Award Plan** 

**2020 Employee Stock Purchase Plan**

**(Full title of the plans)** 

**Nicholas T. Curtis**

**Chief Executive Officer** 

**LENSAR, Inc.** 

**2800 Discovery Drive,** 

**Orlando, FL 32826** 

**(888) 536-7271** 

**(Name, address, including zip code, and telephone number, including area code, of agent for service)** 

***Copies to:*** 

**B. Shayne Kennedy** 

**Drew Capurro** 

**Latham & Watkins LLP** 

**650 Town Center Drive, 20th Floor** 

**Costa Mesa, CA 92626** 

**(714) 540-1235**

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☐ | Accelerated filer | ☐ |
| Non-accelerated filer | ☒ | Smaller reporting company | ☒ |
|  |  | Emerging growth company | ☐ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

------

**EXPLANATORY NOTE**

This Registration Statement on Form S-8 (the "Registration Statement") is being filed with the Securities and Exchange Commission (the "Commission") for the purpose of registering an additional 719,565 shares of common stock, par value $0.01 per share (the "Common Stock"), of LENSAR, Inc. (the "Registrant") issuable under the following employee benefit plans for which registration statements of the Registrant on Form S-8 (File Nos. [<u>333-249323</u>](https://www.sec.gov/Archives/edgar/data/1320350/000119312520263983/d39101ds8.htm), [<u>333-263276</u>](https://www.sec.gov/Archives/edgar/data/1320350/000156459022008592/lnsr-s8.htm), [<u>333-270703</u>](https://www.sec.gov/Archives/edgar/data/1320350/000095017023008804/lnsr-s8-2023.htm), [<u>333-277665</u>](https://www.sec.gov/Archives/edgar/data/1320350/000095017024025880/lnsr-s8-2024.htm) and [<u>333-285465</u>](https://www.sec.gov/Archives/edgar/data/1320350/000095017025030148/lnsr-s8-2025.htm)) are effective: (i) the 2020 Incentive Award Plan, pursuant to the automatic annual increase provision therein, which added 599,638 shares of Common Stock, and (ii) the 2020 Employee Stock Purchase Plan, pursuant to the automatic annual increase provision therein, which added 119,927 shares of Common Stock.

Pursuant to General Instruction E of Form S-8, the contents of the above-referenced prior registration statements are incorporated into this Registration Statement by reference to the extent not modified or superseded hereby or by any subsequently filed document, which is incorporated by reference herein or therein.

**PART II**

**INFORMATION REQUIRED IN THE REGISTRATION STATEMENT**

**Item 8. Exhibits.** 

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Exhibit** | | | **Incorporated by Reference** | **Incorporated by Reference** | **Incorporated by Reference** | |
| **Number** | <br>**Exhibit Description** | <br>**Form** | **File Number** | **Filing Date** | **Exhibit** | **Filed**<br>**Herewith** |
| 3.1 | [<u>Amended and Restated Certificate of Incorporation of LENSAR, Inc.</u>](https://www.sec.gov/Archives/edgar/data/1320350/000119312520262511/d98252dex31.htm) | 8-K | 001-39473 | 10/02/2020 | 3.1 |  |
| 3.2 | [<u>Amended and Restated Bylaws of LENSAR, Inc.</u>](https://www.sec.gov/Archives/edgar/data/1320350/000095017024123534/lnsr-ex3_2.htm) | 10-Q | 001-39473 | 11/07/2024 | 3.2 |  |
| 3.3 | [<u>Certificate of Designations, Preferences and Rights of Series A Convertible Preferred Stock filed May 18, 2023</u>](https://www.sec.gov/Archives/edgar/data/1320350/000119312523148214/d487803dex31.htm) | 8-K | 001-39473 | 05/18/2023 | 3.1 |  |
| 4.1 | [<u>Form of Certificate of Common Stock</u>](https://www.sec.gov/Archives/edgar/data/1320350/000119312520245277/d945311dex41.htm) | 10/A | 001-39473 | 09/14/2020 | 4.1 |  |
| 5.1 | [<u>Opinion of Latham & Watkins LLP</u>](lnsr-ex5_1.htm) |  |  |  |  | X |
| 23.1 | [<u>Consent of Independent Registered Public Accounting Firm (PricewaterhouseCoopers LLP)</u>](lnsr-ex23_1.htm) |  |  |  |  | X |
| 23.2 | [<u>Consent of Latham & Watkins LLP (included in Exhibit 5.1)</u>](lnsr-ex5_1.htm) |  |  |  |  | X |
| 24.1 | [<u>Power of Attorney (included on signature page)</u>](#signatures) |  |  |  |  | X |
| 99.1 | [<u>2020 Incentive Award Plan</u>](https://www.sec.gov/Archives/edgar/data/0001320350/000119312520263983/d39101dex101.htm) | S-8 | 001-39473 | 10/05/2020 | 10.1 |  |
| 99.2 | [<u>Form of Restricted Stock Award Agreement pursuant to 2020 Incentive Award Plan</u>](https://www.sec.gov/Archives/edgar/data/0001320350/000119312520263983/d39101dex102.htm) | S-8 | 001-39473 | 10/05/2020 | 10.2 |  |

---

------

99.3 [<u>Form of Stock Option Agreement pursuant to 2020 Incentive Award Plan</u>](https://www.sec.gov/Archives/edgar/data/1320350/000156459022008556/lnsr-ex105_9.htm) 10-K 001-39473 03/03/2022 10.5

99.4 [<u>Form of Restricted Stock Unit Agreement pursuant to 2020 Incentive Award Plan</u>](https://www.sec.gov/Archives/edgar/data/1320350/000156459022008556/lnsr-ex106_6.htm) 10-K 001-39473 03/03/2022 10.6

99.5 [<u>Form of Performance Stock Unit Agreement pursuant to 2020 Incentive Award Plan</u>](https://www.sec.gov/Archives/edgar/data/1320350/000095017024056837/lnsr-ex10_2.htm) 10-Q 001-39473 05/09/2024 10.2

99.6 [<u>Form of Performance Restricted Stock Unit Agreement – Director Deferral pursuant to 2020 Incentive Award Plan</u>](https://www.sec.gov/Archives/edgar/data/1320350/000095017024056837/lnsr-ex10_3.htm) 10-Q 001-39473 05/09/2024 10.3

99.7 [<u>2020 Employee Stock Purchase Plan</u>](https://www.sec.gov/Archives/edgar/data/1320350/000119312520245277/d945311dex105.htm) 10/A 001-39473 09/14/2020 10.5

107.1 [<u>Filing Fee Table</u>](lnsr_exfilingfees.htm) X

------

**SIGNATURES** 

Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Orlando, State of Florida, on June 2, 2026.

---

| | |
|:---|:---|
| **LENSAR, INC.** | **LENSAR, INC.** |
| By | /s/ Nicholas T. Curtis |
|  | Nicholas T. Curtis |
|  | Chief Executive Officer |

---

**SIGNATURES AND POWER OF ATTORNEY** 

We, the undersigned officers and directors of LENSAR, Inc., hereby severally constitute and appoint Nicholas T. Curtis and Michael A. Rossi, and each of them singly (with full power to each of them to act alone), our true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution in each of them for him and in his name, place and stead, and in any and all capacities, to sign this registration statement and any and all amendments (including post-effective amendments) to this registration statement and all documents relating thereto, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite or necessary to be done in and about the premises, as full to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents or any of them, or their or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, as amended, this registration statement has been signed by the following persons in the capacities held on the dates indicated.

---

| | | |
|:---|:---|:---|
| **Name** | **Title** | **Date** |
| /s/ Nicholas T. Curtis  | Chief Executive Officer and Director<br>(*principal executive officer*) | June 2, 2026 |
| **Nicholas T. Curtis** |  |  |
| /s/ Michael A. Rossi  | Interim Chief Financial Officer<br>(*principal financial officer*) | June 2, 2026 |
| **Michael A. Rossi** |  |  |
| /s/ Kendra W. Wong  | Principal Accounting Officer<br>(*principal accounting officer*) | June 2, 2026 |
| **Kendra W. Wong** |  |  |
| /s/ William J. Link, Ph.D. | Chairperson of the Board of Directors | June 2, 2026 |
| **William J. Link, Ph.D.** |  |  |
| /s/ Thomas B. Ellis | Director | June 2, 2026 |
| **Thomas B. Ellis** |  |  |
| /s/ Todd B. Hammer | Director | June 2, 2026 |
| **Todd B. Hammer** |  |  |

---

------

---

| | | |
|:---|:---|:---|
| /s/ Richard L. Lindstrom, M.D. | Director | June 2, 2026 |
| **Richard L. Lindstrom, M.D.** |  |  |
| /s/ Elizabeth G. O'Farrell | Director | June 2, 2026 |
| **Elizabeth G. O'Farrell** |  |  |
| /s/ Aimee S. Weisner | Director | June 2, 2026 |
| **Aimee S. Weisner** |  |  |
| /s/ Gary M. Winer | Director | June 2, 2026 |
| **Gary M. Winer** |  |  |

---

------

## Exhibit 5.1

Exhibit 5.1

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;1271 Avenue of the Americas | &nbsp;&nbsp;&nbsp;1271 Avenue of the Americas |
| &nbsp;&nbsp;&nbsp;New York, New York 10020-1401 | &nbsp;&nbsp;&nbsp;New York, New York 10020-1401 |
| &nbsp;&nbsp;&nbsp;Tel: +1.212.906.1200 Fax: +1.212.751.4864 | &nbsp;&nbsp;&nbsp;Tel: +1.212.906.1200 Fax: +1.212.751.4864 |
| &nbsp;&nbsp;&nbsp;www.lw.com | &nbsp;&nbsp;&nbsp;www.lw.com |
| &nbsp;&nbsp;&nbsp;FIRM / AFFILIATE OFFICES | &nbsp;&nbsp;&nbsp;FIRM / AFFILIATE OFFICES |
| &nbsp;&nbsp;&nbsp;Austin | &nbsp;&nbsp;&nbsp;Milan |
| &nbsp;&nbsp;&nbsp;Beijing | &nbsp;&nbsp;&nbsp;Munich |
| &nbsp;&nbsp;&nbsp;Boston | &nbsp;&nbsp;&nbsp;New York |
| &nbsp;&nbsp;&nbsp;Brussels | &nbsp;&nbsp;&nbsp;Orange County |
| &nbsp;&nbsp;&nbsp;Century City | &nbsp;&nbsp;&nbsp;Paris |
| &nbsp;&nbsp;&nbsp;Chicago | &nbsp;&nbsp;&nbsp;Riyadh |
| &nbsp;&nbsp;&nbsp;Dubai | &nbsp;&nbsp;&nbsp;San Diego |
| &nbsp;&nbsp;&nbsp;Düsseldorf | &nbsp;&nbsp;&nbsp;San Francisco |
| &nbsp;&nbsp;&nbsp;Frankfurt | &nbsp;&nbsp;&nbsp;Seoul |
| &nbsp;&nbsp;&nbsp;Hamburg | &nbsp;&nbsp;&nbsp;Silicon Valley |
| &nbsp;&nbsp;&nbsp;Hong Kong | &nbsp;&nbsp;&nbsp;Singapore |
| &nbsp;&nbsp;&nbsp;Houston | &nbsp;&nbsp;&nbsp;Tel Aviv |
| &nbsp;&nbsp;&nbsp;London | &nbsp;&nbsp;&nbsp;Tokyo |
| &nbsp;&nbsp;&nbsp;Los Angeles | &nbsp;&nbsp;&nbsp;Washington, D.C. |
| &nbsp;&nbsp;&nbsp;Madrid |  |

---

![img42473883_0.jpg](img42473883_0.jpg)

June 2, 2026

LENSAR, Inc.

2800 Discovery Drive

Orlando, Florida 32826

Re: <u>Registration Statement on Form S-8 with respect to 719,565 shares of common stock, par value $0.01 per share, of LENSAR, Inc.</u> 

To the addressees set forth above:

We have acted as special counsel to LENSAR, Inc., a Delaware corporation (the "Company"), in connection with the proposed issuance by the Company of up to 719,565 shares of common stock of the Company, par value $0.01 per share (the "Common Stock"), comprised of up to 599,638 shares of Common Stock (the "Plan Shares") issuable under the Company's 2020 Incentive Award Plan (the "2020 Plan") and up to 119,927 shares of Common Stock (the "ESPP Shares" and, together with the Plan Shares, the "Shares") issuable under the Company's 2020 Employee Stock Purchase Plan (the "ESPP"). The Shares are included in a registration statement on Form S-8 under the Securities Act of 1933, as amended (the "Act"), filed with the Securities and Exchange Commission (the "Commission") on May 4, 2026 (the "Registration Statement"). This opinion is being furnished in connection with the requirements of Item 601(b)(5) of Regulation S-K under the Act, and no opinion is expressed herein as to any matter pertaining to the contents of the Registration Statement or prospectuses forming a part thereof, other than as expressly stated herein with respect to the issuance of the Shares.

As such counsel, we have examined such matters of fact and questions of law as we have considered appropriate for purposes of this letter. With your consent, we have relied upon the foregoing and upon certificates and other assurances of officers of the Company and others as to factual matters without having independently verified such factual matters. We are opining herein only as to the General Corporation Law of the State of Delaware (the "DGCL"), and we express no opinion with respect to any other laws.

Subject to the foregoing and the other matters set forth herein, it is our opinion that, as of the date hereof, when the Shares shall have been duly registered on the books of the transfer agent and registrar therefor in the name or on behalf of the recipients thereof, and have been issued by the Company for legal consideration in excess of par value in the circumstances contemplated by the 2020 Plan or the ESPP, as applicable, and assuming in each case that the individual issuances, grants or awards under the 2020 Plan or the ESPP, as applicable, are duly authorized by all necessary corporate action and duly issued, granted or awarded and exercised in accordance with the requirements of law and the 2020 Plan or the ESPP (and the agreements and awards duly adopted thereunder and in accordance therewith), as applicable, the issue and sale of the Shares will have been duly authorized by all necessary corporate action of the Company, and such Shares will be validly issued, fully paid and non-assessable. In rendering the

------

foregoing opinion, we have assumed that the Company will comply with all applicable notice requirements regarding uncertificated shares provided in the DGCL.

This opinion is for your benefit in connection with the Registration Statement and may be relied upon by you and by persons entitled to rely upon it pursuant to the applicable provisions of the Act. We consent to your filing this opinion as an exhibit to the Registration Statement. In giving such consent, we do not thereby admit that we are in the category of persons whose consent is required under Section 7 of the Act or the rules and regulations of the Commission thereunder.

Sincerely,

/s/ Latham & Watkins LLP

------

## Exhibit 23.1

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in this Registration Statement on Form S-8 of LENSAR, Inc. of our report dated March 31, 2026 relating to the financial statements, which appears in LENSAR, Inc.'s Annual Report on Form 10-K for the year ended December 31, 2025.

/s/ PricewaterhouseCoopers LLP<br>Raleigh, North Carolina<br>June 2, 2026

------

## Ex-Filing

?xml version='1.0' encoding='ASCII'? EX-FILING FEES

**Exhibit 107.1**

**Calculation of** Filing Fee **Tables**

**Form** S-8

(Form Type)

LENSAR, Inc.

(Exact Name of Registrant as Specified in its Charter)

**Table 1—Newly Registered Securities**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Plan** | **Security Type** | **Security Class Title** | **Fee Recalculation Rule** | **Amount to be Registered** <sup>(1)</sup> | **Proposed Maximum Offering Price Per Unit** | **Maximum Aggregate Offering Price** | **Fee Rate** | **Amount of Registration Fee** |
| 2020 Incentive Award Plan | Equity | Common stock, $0.01 par value per share | Rule 457(c) and Rule 457(h) | 599638<br><sup>(2)</sup> | $5.79<br><sup>(4)</sup> | $3471904.02 | $138.10 per $1,000,000 | $479.47 |
| 2020 Employee Stock Purchase Plan | Equity | Common stock, $0.01 par value per share | Rule 457(c) and Rule 457(h) | 119927<br><sup>(3)</sup> | $5.79<br><sup>(4)</sup> | $694377.33 | $138.10 per $1,000,000 | $95.89 |
|  | **Total Offering Amounts** | **Total Offering Amounts** | **Total Offering Amounts** | 719565 |  | $4166281.35 |  | $575.36 |
|  | **Total Fee Offsets** <sup>(5)</sup> | **Total Fee Offsets** <sup>(5)</sup> | **Total Fee Offsets** <sup>(5)</sup> |  |  |  |  | $0.00 |
|  | **Net Fee Due** | **Net Fee Due** | **Net Fee Due** |  |  |  |  | $575.36 |

---

(1)In accordance with Rule 416 under the Securities Act of 1933, as amended, this registration statement shall be deemed to cover any additional securities that may from time to time be offered or issued to prevent dilution resulting from stock splits, stock dividends or similar transactions.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)Consists of 599,638 shares of the Registrant's Common Stock that became available for issuance on January 1, 2026 under the Registrant's 2020 Incentive Award Plan by operation of an automatic annual increase provision therein.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)Consists of 119,927 shares of the Registrant's Common Stock that became available for issuance on January 1, 2026 under the Registrant's 2020 Employee Stock Purchase Plan by operation of an automatic annual increase provision therein.

(4)Estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(c) and 457(h) of the Securities Act of 1933, as amended, and based upon the average of the high and low prices of the Registrant's Common Stock as reported on The Nasdaq Stock Market LLC on June 1, 2026.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(5)The Registrant does not have any fee offsets.

------